Reported about 1 month ago
Walmart announced a proposed settlement for three shareholder lawsuits related to its handling of prescription opioids, involving a payment of $123 million from insurance carriers. The settlement requires Walmart to uphold certain corporate governance practices for five years, but it does not imply any admission of liability and is pending court approval. Shareholders had accused company directors of failing to properly oversee opioid distribution.
Source: YAHOO